Skip to content

Assembly Biosciences ASMB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Efficiency
Asset turnover0.4×+0.1×0.4×+0.2×0.2×-0.2×0.3×+0.1×0.3×+0.2×
Liquidity
Current ratio6.6×+4.6×5.2×+2.8×4.4×+2.1×1.6×-1.1×-1.0×
Quick ratio6.6×+4.6×5.2×+2.8×4.4×+2.1×1.6×-1.1×-1.0×
Cash ratio0.9×+0.4×1.2×+0.4×0.4×-0.3×0.5×0.0×0.5×0.0×
Leverage
Debt-to-equity-0.1×-0.1×0.0×0.2×+0.1×0.1×+0.1×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$11.75+225%$18.44+232%$14.40+252%$2.36-61.5%$3.61-39.2%
Valuation
Market capitalization$480.77M+262%$537.94M+436%$196.41M+104%$131.37M+50.9%$71.73M-1.6%
Enterprise value$452.14M+302%$482.12M+641%$176.63M+156%$110.24M+58.4%$51.34M-8.5%
Price / sales6.8×+2.6×7.4×+3.9×5.3×+1.9×-0.1×2.2×-3.4×
Price / book2.4×-2.5×2.6×-0.4×1.1×-2.6×7.3×+4.7×2.6×+0.4×
EV / sales6.4×+2.9×6.7×+4.4×4.7×+2.3×3.3×+0.1×1.6×-2.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Assembly Biosciences's ratios come from?
Every ratio is computed from Assembly Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.